Crossmark

Diabetes Mellitus Type 2 as a Risk Factor and Outcome Modifier for Cryptococcosis in HIV Negative, Non-transplant Patients, a Propensity Score Match Analysis

Crossref DOI link: https://doi.org/10.1007/s00284-023-03512-9

Published Online: 2023-10-31

Published Print: 2023-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kung, Vanessa M.

Ferraz, Carolina

Kennis, Matthew

Franco-Paredes, Carlos

Tuells, Jose

Vargas Barahona, Lilian

Shapiro, Leland

Thompson, George R. III

Chastain, Daniel B.

Henao-Martínez, Andrés F. https://orcid.org/0000-0001-7363-8652
License Information

Text and Data Mining valid from 2023-10-31

Version of Record valid from 2023-10-31
More Information

Article History

Received: 20 July 2023

Accepted: 3 October 2023

First Online: 31 October 2023

Declarations

:

: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr Shapiro reports receiving grants from the Emily Foundation for Medical Research during the study. Dr Henao-Martínez reported receiving a K12-clinical trial award as a co-principal investigator for the Expanded Access IND Program (EAP) to provide the Yellow Fever vaccine (Stamaril) to persons in the United States outside the submitted work. No other disclosures were reported.

: Research utilizing TriNetX does not require ethical approval because patient-identifiable information is not accessible to users. The current project is in Health Insurance Portability and Accountability Act (HIPAA) compliance according to the Colorado Multiple Institutional Review Board (COMIRB) at the University of Colorado Denver. Analysis of clinical data was performed under an approved protocol.

: Not applicable.

Document is current

Any future updates will be listed below